To investigate whether TSP4 represents a CSF biomarker specific for SMA in pediatric patients, we moreover analyzed CSF derived from pediatric patients suffering from other neurological diseases thus serving as disease controls. This evidence concerns the gene THBS4 and proximal spinal muscular atrophy.